Skip to content

Clinical trials

Completed Metabolic Diseases trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Metabolic Diseases Status: Completed Country / region: Brazil Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20072
20082
20091
20111
20141
20151
20161
20171
20182
20201
20223

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company4
Kastle Therapeutics, LLC2
University of Sao Paulo2
Alexion Pharmaceuticals, Inc.1
AstraZeneca1
Federal University of Rio Grande do Sul1
Hospital de Clinicas de Porto Alegre1
Ionis Pharmaceuticals, Inc.1
Takeda1
Ultragenyx Pharmaceutical Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Metabolic Diseases16
Diabetes Mellitus, Type 27
Diabetes Mellitus6
Glucose Metabolism Disorders6
Endocrine System Diseases5
Genetic Diseases, Inborn3
Hyperlipidemias3
Infant, Newborn, Diseases3
Lipid Metabolism Disorders3
Lipid Metabolism, Inborn Errors3

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.